Valerio Therapeutics Société anonyme (LON:0NWK)
London · Delayed Price · Currency is GBP · Price in EUR 0.0566
+0.0032 (5.99%)
At close: Jul 15, 2025
LON:0NWK Revenue
In the year 2024, Valerio Therapeutics Société anonyme had annual revenue of 1.79M EUR, down -0.39%. Valerio Therapeutics Société anonyme had revenue of 1.70M in the half year ending December 31, 2024, with 18.09% growth.
Revenue
1.79M EUR
Revenue Growth
-0.39%
P/S Ratio
4.84
Revenue / Employee
94.37K EUR
Employees
19
Market Cap
7.18M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.79M | -7.00K | -0.39% |
| Dec 31, 2023 | 1.80M | 357.00K | 24.74% |
| Dec 31, 2022 | 1.44M | -2.62M | -64.48% |
| Dec 31, 2021 | 4.06M | 2.29M | 128.72% |
| Dec 31, 2020 | 1.78M | -2.51M | -58.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |